BackSino Biopharmaceutical Overview

Sino Biopharmaceutical Gross Profit

Gross Profit analysis for SBHMY.

Quarterly Gross Profit

$7.25B
↑ 301.33% YoY

As of Jun 30, 2025

Annual Gross Profit (TTM)

$24.99B
↑ 419.67% YoY

Trailing 12 months ending Jun 30, 2025

Average Gross Profit (Comparison Companies)

Gross Profit History

Gross Profit Comparison

Annual Gross Profit Growth Rate (%)

Annual Gross Profit Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin